Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase
评估利拉鲁肽、恩格列净和利格列汀对2型糖尿病患者轻度认知障碍缓解的影响(LIGHT-MCI):一项多中心、随机对照试验及扩展阶段的研究方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-095382
Yu, Congcong; Yang, Huijie; Zhang, Bing; Chen, Shihua; Yang, Sijue; Li, Fangyi; Zhu, Wenhui; Zhai, Beibei; Wu, Tianyu; Zhao, Shengyi; Zhang, Wen; Tong, Xuewei; Duan, Yanjie; Zhang, Lu; Chao, Yining; Wu, Jindan; Zhu, Xiaowei; Wang, Kun; Ye, Xinhua; Zhang, Xiaoya; Xu, Xiang; Cheng, Haiyan; Liu, Jie; Zhang, Jie; Wang, Ying; Zhang, Zhou; Yan, Weili; Bi, Yan